Abstract
Second-tier glycosaminoglycan analysis in dried blood spots by the endogenous non-reducing end method provides the best approach for reducing false positives in newborn screening of all sub-types of mucopolysaccharidoses
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have